François Diévart
About
François Diévart is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, François Diévart has authored 23 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in François Diévart's work include Blood Pressure and Hypertension Studies (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). François Diévart is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Arrhythmias and Treatments (3 papers). François Diévart collaborates with scholars based in France, United Kingdom and Italy. François Diévart's co-authors include Patrice Darmon, Jean‐Michel Halimi, Bruno Guerci, Pierre Gourdy, Michel Galinier, Marc Ferrini, Isabella Sudano, Véronique Cornelissen, Claudio Ceconi and Felix Mahfoud and has published in prestigious journals such as International Journal of Molecular Sciences, European Heart Journal and Intensive Care Medicine.
In The Last Decade
François Diévart
19 papers receiving 400 citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| François Diévart France | 9 | 191 | 90 | 70 | 58 | 49 | 23 | 413 | ||
| Bojan Jelaković Croatia | 10 | 188 1.0× | 122 1.4× | 31 0.4× | 61 1.1× | 35 0.7× | 39 | 473 | ||
| Chi Wang China | 9 | 269 1.4× | 79 0.9× | 101 1.4× | 26 0.4× | 55 1.1× | 33 | 516 | ||
| Katsuhito Kato Japan | 10 | 218 1.1× | 116 1.3× | 61 0.9× | 30 0.5× | 98 2.0× | 37 | 426 | ||
| Donald L. Batisky United States | 14 | 250 1.3× | 75 0.8× | 57 0.8× | 85 1.5× | 54 1.1× | 27 | 499 | ||
| Vesna Degoricija Croatia | 12 | 162 0.8× | 74 0.8× | 116 1.7× | 34 0.6× | 93 1.9× | 50 | 452 | ||
| Yingxian Sun China | 8 | 100 0.5× | 75 0.8× | 99 1.4× | 67 1.2× | 57 1.2× | 11 | 303 | ||
| Seyed Mehrdad Hamrahian United States | 8 | 155 0.8× | 41 0.5× | 28 0.4× | 67 1.2× | 28 0.6× | 11 | 346 | ||
| Maoxiang Zhao China | 8 | 348 1.8× | 158 1.8× | 123 1.8× | 67 1.2× | 70 1.4× | 39 | 604 | ||
| Helga Gudmundsdottir Norway | 13 | 162 0.8× | 42 0.5× | 39 0.6× | 94 1.6× | 30 0.6× | 25 | 381 | ||
| Tatsuya Kamon Japan | 15 | 353 1.8× | 122 1.4× | 106 1.5× | 26 0.4× | 71 1.4× | 40 | 586 |
Countries citing papers authored by François Diévart
Since
Specialization
Citations
This map shows the geographic impact of François Diévart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Diévart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Diévart more than expected).
Fields of papers citing papers by François Diévart
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by François Diévart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Diévart. The network helps show where François Diévart may publish in the future.
Co-authorship network of co-authors of François Diévart
This figure shows the co-authorship network connecting the top 25 collaborators of François Diévart. A scholar is included among the top collaborators of François Diévart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Diévart. François Diévart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bergerot, Cyrille, L. Groisne, Joseph Emmerich, François Diévart, & Franck Boccara. (2025). ESC/EAS 2025 dyslipidaemia guidelines update: Don’t get left behind!. Archives of cardiovascular diseases. 119(2). 105–107.
2.
Diévart, François, et al.. (2025). Single-lead electrocardiograms and artificial intelligence for managing cardiac rhythm irregularities in general practice: A French general practitioners’ survey. Archives of cardiovascular diseases. 118(11). 582–587.
3.
Diévart, François, David Jacobi, Denis Angoulvant, et al.. (2025). Onboarding obesity management in cardiovascular care: A cardiologist's guide to latest advances. American Journal of Preventive Cardiology. 22. 100987–100987.
4.
Pedretti, Roberto F.E., Riccardo Asteggiano, Andreas B. Gevaert, et al.. (2025). Cardiovascular risk factors management in older adults: a clinical consensus statement from the European Association of Preventive Cardiology of the ESC and the ESC Council for Cardiology Practice. European Journal of Preventive Cardiology.
5.
Diévart, François, Éric Bruckert, Victor Aboyans, et al.. (2024). Management of lipid variables in primary cardiovascular prevention: A position paper from the Heart, Vessels and Metabolism Group of the French Society of Cardiology. Archives of cardiovascular diseases. 117(5). 358–378.
6.
Gourdy, Pierre, Patrice Darmon, François Diévart, Jean‐Michel Halimi, & Bruno Guerci. (2023). Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM). Cardiovascular Diabetology. 22(1). 79–79.
7.
Diévart, François, Patrice Darmon, Jean‐Michel Halimi, et al.. (2023). Quand et comment utiliser les inhibiteurs de SGLT2 ou gliflozines en pratique clinique ? Un consensus proposé par la Société francophone du diabète (SFD), la Société française de cardiologie (SFC), le Collège national des cardiologues français (CNCF) et la Société francophone de néphrologie, dialyse et transplantation (SFNDT). Néphrologie & Thérapeutique. 19(4). 251–277.
8.
Gerdts, Eva, Isabella Sudano, Sofie Brouwers, et al.. (2022). Sex differences in arterial hypertension. European Heart Journal. 43(46). 4777–4788.
9.
Richter, Dimitrios, Luigina Guasti, Friedrich Koehler, et al.. (2021). Late Phase of COVID-19 Pandemic in General Cardiology. A Position Paper of the ESC Council for Cardiology Practice. ESC Heart Failure. 8(5). 3483–3494.
10.
Gaubert, Mélanie, Thomas Bardin, Alain Cohen‐Solal, et al.. (2020). Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice. International Journal of Molecular Sciences. 21(11). 4066–4066.
11.
Bejan‐Angoulvant, Théodora, et al.. (2016). Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation: A meta analysis of adjusted analysis in routine practice settings. International Journal of Cardiology. 206. 89–92.
12.
Ragot, Stéphanie, P. Sosner, François Diévart, & D Herpin. (2014). Prevalence and management of uncontrolled hypertension in French patients aged over 80 years. Archives of cardiovascular diseases. 107(4). 236–244.
13.
Blacher, Jacques, Ariel Cohen, Jean‐Philippe Collet, et al.. (2011). Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data. Archives of cardiovascular diseases. 104(2). 115–124.
14.
Hagège, Albert, et al.. (2010). First evaluation using a validated scale of the risk of congestive heart failure among hypertensive patients treated by general practitioners (O-PREDICT survey). Archives of cardiovascular diseases. 103(3). 176–183.
15.
Jourdain, Patrick, Guillaume Lefèvre, Christiane Oddoze, et al.. (2009). NT-proBNP en pratique « De la biologie à la clinique ». Annales de Cardiologie et d Angéiologie. 58(3). 165–179.
16.
Jourdain, Patrick, Guillaume Lefèvre, Christiane Oddoze, et al.. (2009). NT-proBNP en pratique «De la biologie à la clinique». Annales de biologie clinique. 67(3). 255–271.
17.
Danchin, Nicolas, et al.. (2008). Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey. International Journal of Cardiology. 133(1). 32–40.
18.
Groote, Pascal de, D Herpin, François Diévart, et al.. (2008). Treatment of heart failure with preserved systolic function. Archives of cardiovascular diseases. 101(5). 361–372.
19.
Danchin, Nicolas, et al.. (2006). Prévention secondaire après syndrome coronaire aigu sans sus-décalage de ST en fonction de l'utilisation de l'angioplastie coronaire: l'étude S-Témoin. Annales de Cardiologie et d Angéiologie. 56(1). 30–35.
20.
Durocher, Alain, F. Saulnier, R. Beuscart, et al.. (1988). A comparison of three severity score indexes in an evaluation of serious bacterial pneumonia. Intensive Care Medicine. 14(1). 39–43.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bojan Jelaković Breakdown of academic impact, for papers by Chi Wang Breakdown of academic impact, for papers by Katsuhito Kato Breakdown of academic impact, for papers by Donald L. Batisky Breakdown of academic impact, for papers by Vesna Degoricija Breakdown of academic impact, for papers by Yingxian Sun Breakdown of academic impact, for papers by Seyed Mehrdad Hamrahian Breakdown of academic impact, for papers by Maoxiang Zhao Breakdown of academic impact, for papers by Helga Gudmundsdottir Breakdown of academic impact, for papers by Tatsuya Kamon